Who invested in Sunstone Therapies

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Healthcare

Funding summaryUpdated 26 Oct 2026

$8.5Mraised across 1 round since 2024, from 1 source

Latest round: Venture, $8.5MJul 2024
Investors: 2

See who backed them

The rounds

Jul 2024
Venture$8.5M
- Y Combinator
- AlleyCorp
Source recordedSEC filing: $8.5M sold, first sale Dec 2023

Founders and team

From Sunstone Therapies's own website: 16 on the team.

Ambrah ThomasResearch Coordinator
Chris JinClinical Research Coordinator II
Ericka FosterCommunications Coordinator
Jake SandlerChief of Staff
Julie Y. SandlerChief Growth Officer
Lead Clinical Evaluation SpecialistLead Clinical Research Coordinator
Jim ByrdVP Finance
Eakta AgrawalClinical Systems Manager
Eloise CherianPatient Evaluation & Clinical Research Communications Specialist
Jessica StotlerRegulatory Affairs Manager
Kim MaillieResearch Data Manager
Laura VolovskiMarketing Communications Manager
Lindsay AmannPatient Evaluation & Communications Specialist
Lindsay OzyckBusiness Systems Manager
Maryam AzarionLegal Counsel
Mehwish SajjadClinical Scheduling Analyst

Everyone who backed them

Y CombinatorAccelerator1round

AlleyCorpVenture studio1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Sunstone Therapies as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.